Review and clinical update on parenteral nutrition-associated liver disease

Nutrition in Clinical Practice

Volumn 28, Issue 1, 2013, Pages 30-39

  Tillman, Emma M ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

cholestasis; fat emulsions, intravenous; fatty acids, omega 3; fatty acids, omega 6; parenteral nutrition; parenteral nutrition, home

Indexed keywords

AMINO ACID; ANTIBIOTIC AGENT; BILIRUBIN; BIOCHEMICAL MARKER; CHOLECYSTOKININ; FISH OIL; GLUCOSE; LINOLEIC ACID; LONG CHAIN FATTY ACID; MEDIUM CHAIN TRIACYLGLYCEROL; OLIVE OIL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; OMEGAVEN; PHYTOSTEROL; SMOFLIPID; SOYBEAN OIL EMULSION; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ANEMIA; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ASTHMA; AUTOIMMUNE DISEASE; BILIRUBIN BLOOD LEVEL; BURR CELL ANEMIA; CARBOHYDRATE INTAKE; CARDIOVASCULAR DISEASE; CHEMICAL COMPOSITION; CHOLESTASIS; CLINICAL FEATURE; DIET RESTRICTION; DRUG MECHANISM; DRUG WITHDRAWAL; ENTERIC FEEDING; ESSENTIAL FATTY ACID DEFICIENCY; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER INJURY; NEOPLASM; NONHUMAN; OUTCOME ASSESSMENT; PACKAGING; PARENTERAL NUTRITION; PARENTERAL NUTRITION ASSOCIATED LIVER DISEASE; PATHOPHYSIOLOGY; PROTEIN RESTRICTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEPSIS; SHORT BOWEL SYNDROME; SURGICAL PATIENT;

FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; HUMANS; LIVER; LIVER DISEASES; PARENTERAL NUTRITION; RISK FACTORS; TREATMENT OUTCOME;

EID: 84872380359     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533612462900     Document Type: Review

References (79)

1. Beale EF, Nelson RM, Bucciarelli RL, Donnelly WH, Eitzman DV. Intrahepatic cholestasis associated with parenteral nutrition in premature infants. Pediatrics. 1979 ; 64 (3). 342-347
2. Sinatra FR. Cholestasis in infancy and childhood. Curr Probl Pediatr. 1982 ; 12 (12). 1-54
3. Whitington PF. Cholestasis associated with total parenteral nutrition in infants. Hepatology. 1985 ; 5 (4). 693-696
4. Fishbein TM. Intestinal transplantation. N Engl J Med. 2009 ; 361 (10). 998-1008
5. Javid PJ, Kim HB, Duggan CP, Jaksic T. Serial transverse enteroplasty is associated with successful short-term outcomes in infants with short bowel syndrome. J Pediatr Surg. 2005 ; 40 (6). 1019-1023
6. Willis TC, Carter BA, Rogers SP, Hawthorne KM, Hicks PD, Abrams SA. High rates of mortality and morbidity occur in infants with parenteral nutrition-associated cholestasis. JPEN J Parenter Enteral Nutr. 2010 ; 34 (1). 32-37
7. Javid PJ, Collier S, Richardson D, et al. The role of enteral nutrition in the reversal of parenteral nutrition-associated liver dysfunction in infants. J Pediatr Surg. 2005 ; 40 (6). 1015-1018
8. Merritt RJ. Cholestasis associated with total parenteral nutrition. J Pediatr Gastroenterol Nutr. 1986 ; 5 (1). 9-22
9. Moss RL, Das JB, Raffensperger JG. Necrotizing enterocolitis and total parenteral nutrition-associated cholestasis. Nutrition. 1996 ; 12 (5). 340-343
10. Carter BA, Shulman RJ. Mechanisms of disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis. Nat Clin Pract Gastroenterol Hepatol. 2007 ; 4 (5). 277-287
11. Copple BL, Jaeschke H, Klaassen CD. Oxidative stress and the pathogenesis of cholestasis. Semin Liver Dis. 2010 ; 30 (2). 195-204
12. Spencer AU, Yu S, Tracy TF, et al. Parenteral nutrition-associated cholestasis in neonates: multivariate analysis of the potential protective effect of taurine. JPEN J Parenter Enteral Nutr. 2005 ; 29 (5). 337-343
13. Colomb V, Jobert-Giraud A, Lacaille F, Goulet O, Fournet JC, Ricour C. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enteral Nutr. 2000 ; 24 (6). 345-350
14. Trauner M, Fickert P, Stauber RE. Inflammation-induced cholestasis. J Gastroenterol Hepatol. 1999 ; 14 (10). 946-959
15. Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental pharmacology-drug disposition, action, and therapy in infants and children. N Engl J Med. 2003 ; 349 (12). 1157-1167
16. Moss RL, Haynes AL, Pastuszyn A, Glew RH. Methionine infusion reproduces liver injury of parenteral nutrition cholestasis. Pediatr Res. 1999 ; 45 (5, pt 1). 664-668
17. Alemmari A, Miller GG, Bertolo RF, et al. Reduced aluminum contamination decreases parenteral nutrition associated liver injury. J Pediatr Surg. 2012 ; 47 (5). 889-894
18. Alemmari A, Miller GG, Arnold CJ, Zello GA. Parenteral aluminum induces liver injury in a newborn piglet model. J Pediatr Surg. 2011 ; 46 (5). 883-887
19. Goulet O, Joly F, Corriol O, Colomb-Jung V. Some new insights in intestinal failure-associated liver disease. Curr Opin Organ Transplant. 2009 ; 14 (3). 256-261
20. Driscoll DF, Ling PR, Bistrian BR. Physical stability of 20% lipid injectable emulsions via simulated syringe infusion: effects of glass vs plastic product packaging. JPEN J Parenter Enteral Nutr. 2007 ; 31 (2). 148-153
21. Driscoll DF, Ling PR, Andersson C, Bistrian BR. Hepatic indicators of oxidative stress and tissue damage accompanied by systemic inflammation in rats following a 24-hour infusion of an unstable lipid emulsion admixture. JPEN J Parenter Enteral Nutr. 2009 ; 33 (3). 327-335
22. Balistreri WF. Bile acid therapy in pediatric hepatobiliary disease: the role of ursodeoxycholic acid. J Pediatr Gastroenterol Nutr. 1997 ; 24 (5). 573-589
23. Teitelbaum DH, Tracy TF, Aouthmany MM, et al. Use of cholecystokinin- octapeptide for the prevention of parenteral nutrition-associated cholestasis. Pediatrics. 2005 ; 115 (5). 1332-1340
24. Kaufman SS. Prevention of parenteral nutrition-associated liver disease in children. Pediatr Transplant. 2002 ; 6 (1). 37-42
25. Lambert JR, Thomas SM. Metronidazole prevention of serum liver enzyme abnormalities during total parenteral nutrition. JPEN J Parenter Enteral Nutr. 1985 ; 9 (4). 501-503
26. Jensen AR, Goldin AB, Koopmeiners JS, Stevens J, Waldhausen JH, Kim SS. The association of cyclic parenteral nutrition and decreased incidence of cholestatic liver disease in patients with gastroschisis. J Pediatr Surg. 2009 ; 44 (1). 183-189
27. Kim HB, Fauza D, Garza J, Oh JT, Nurko S, Jaksic T. Serial transverse enteroplasty (STEP): a novel bowel lengthening procedure. J Pediatr Surg. 2003 ; 38 (3). 425-429
28. Gura KM, Parsons SK, Bechard LJ, et al. Use of a fish oil-based lipid emulsion to treat essential fatty acid deficiency in a soy allergic patient receiving parenteral nutrition. Clin Nutr. 2005 ; 24 (5). 839-847
29. Gura KM, Duggan CP, Collier SB, et al. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics. 2006 ; 118 (1). e197 - e201
30. Vanek VW, Seidner DL, Allen P, et al. A.S.P.E.N. position paper: clinical role for alternative intravenous fat emulsions. Nutr Clin Pract. 2012 ; 27 (2). 150-192
31. Salvador A, Janeczko M, Porat R, Sekhon R, Moewes A, Schutzman D. Randomized controlled trial of early parenteral nutrition cycling to prevent cholestasis in very low birth weight infants. J Pediatr. 2012 ; 161 (2). 229-233
32. Alwayn IP, Gura K, Nose V, et al. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr Res. 2005 ; 57 (3). 445-452
33. Lee S, Kim S, Le HD, et al. Reduction of hepatocellular injury after common bile duct ligation using omega-3 fatty acids. J Pediatr Surg. 2008 ; 43 (11). 2010-2015
34. Kohl M, Wedel T, Entenmann A, et al. Influence of different intravenous lipid emulsions on hepatobiliary dysfunction in a rabbit model. J Pediatr Gastroenterol Nutr. 2007 ; 44 (2). 237-244
35. Grimm H, Tibell A, Norrlind B, Blecher C, Wilker S, Schwemmle K. Immunoregulation by parenteral lipids: impact of the n-3 to n-6 fatty acid ratio. JPEN J Parenter Enteral Nutr. 1994 ; 18 (5). 417-421
36. Furst P, Kuhn KS. Fish oil emulsions: what benefits can they bring?. Clin Nutr. 2000 ; 19 (1). 7-14
37. Gura KM, Lee S, Valim C, et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics. 2008 ; 121 (3). e678 - e686
38. Puder M, Valim C, Meisel JA, et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg. 2009 ; 250 (3). 395-402
39. Ekema G, Falchetti D, Boroni G, et al. Reversal of severe parenteral nutrition-associated liver disease in an infant with short bowel syndrome using parenteral fish oil (omega-3 fatty acids). J Pediatr Surg. 2008 ; 43 (6). 1191-1195
40. Cheung HM, Lam HS, Tam YH, Lee KH, Ng PC. Rescue treatment of infants with intestinal failure and parenteral nutrition-associated cholestasis (PNAC) using a parenteral fish-oil-based lipid. Clin Nutr. 2009 ; 28 (2). 209-212
41. Calhoun AW, Sullivan JE. Omegaven for the treatment of parenteral nutrition associated liver disease: a case study. J Ky Med Assoc. 2009 ; 107 (2). 55-57
42. Chung PH, Wong KK, Wong RM, Tsoi NS, Chan KL, Tam PK. Clinical experience in managing pediatric patients with ultra-short bowel syndrome using omega-3 fatty acid. Eur J Pediatr Surg. 2010 ; 20 (2). 139-142
43. Diamond IR, Sterescu A, Pencharz PB, Kim JH, Wales PW. Changing the paradigm: Omegaven for the treatment of liver failure in pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr. 2009 ; 48 (2). 209-215
44. Fitzgibbons SC, Jones BA, Hull MA, et al. Relationship between biopsy-proven parenteral nutrition-associated liver fibrosis and biochemical cholestasis in children with short bowel syndrome. J Pediatr Surg. 2010 ; 45 (1). 95-99
45. Soden JS, Lovell MA, Brown K, Partrick DA, Sokol RJ. Failure of resolution of portal fibrosis during omega-3 fatty acid lipid emulsion therapy in two patients with irreversible intestinal failure. J Pediatr. 2010 ; 156 (2). 327-331
46. Dimmitt RA, Leadford AI, Bartle D, et al. Impact of omega-3 fatty acids on liver function test and liver histology in children with intestinal failure associated intestinal disease. Presented at: Pediatric Academic Society ; Boston, MA ;..
47. Moss RL, Das JB, Raffensperger JG. Total parenteral nutrition-associated cholestasis: clinical and histopathologic correlation. J Pediatr Surg. 1993 ; 28 (10). 1270-1274
48. Hammel P, Couvelard A, O'Toole D, et al. Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med. 2001 ; 344 (6). 418-423
49. Burns DL, Gill BM. Reversal of parenteral nutrition-associated liver disease with a fish oil-based lipid emulsion (Omegaven) in an adult dependent on home parenteral nutrition. JPEN J Parenter Enteral Nutr. :
50. Seida JC, Mager DR, Hartling L, Vandermeer B, Turner JM. Parenteral omega-3 fatty acid lipid emulsions for children with intestinal failure and other conditions: a systematic review. JPEN J Parenter Enteral Nutr. :
51. Rollins MD, Scaife ER, Jackson WD, Meyers RL, Mulroy CW, Book LS. Elimination of soybean lipid emulsion in parenteral nutrition and supplementation with enteral fish oil improve cholestasis in infants with short bowel syndrome. Nutr Clin Pract. 2010 ; 25 (2). 199-204
52. Tillman EM, Crill CM, Black DD, et al. Enteral fish oil for treatment of parenteral nutrition-associated liver disease in six infants with short-bowel syndrome. Pharmacotherapy. 2011 ; 31 (5). 503-509
53. Sharma AA. Supplementing enteral feeds with fish oil improves or reverses the total parenteral nutrition induced cholestasis in 4 infants in neonatal/pediatric intensive care units [abstract]. JPEN J Parenter Enteral Nutr. 2010 ; 34 (2). 231
54. Cober MP, Killu G, Brattain A, Welch KB, Kunisaki SM, Teitelbaum DH. Intravenous fat emulsions reduction for patients with parenteral nutrition-associated liver disease. J Pediatr. 2012 ; 160 (3). 421-427
55. Nehra D, Fallon EM, Carlson SJ, et al. Provision of a soy-based intravenous lipid emulsion at 1 g/kg/d does not prevent cholestasis in neonates. JPEN J Parenter Enteral Nutr. :
56. Piper SN, Schade I, Beschmann RB, Maleck WH, Boldt J, Rohm KD. Hepatocellular integrity after parenteral nutrition: comparison of a fish-oil-containing lipid emulsion with an olive-soybean oil-based lipid emulsion. Eur J Anaesthesiol. 2009 ; 26 (12). 1076-1082
57. Muhammed R, Bremner R, Protheroe S, Johnson T, Holden C, Murphy MS. Resolution of parenteral nutrition-associated jaundice on changing from a soybean oil emulsion to a complex mixed-lipid emulsion. J Pediatr Gastroenterol Nutr. 2012 ; 54 (6). 797-802
58. de Meijer VE, Le HD, Meisel JA, et al. Parenteral fish oil as monotherapy prevents essential fatty acid deficiency in parenteral nutrition-dependent patients. J Pediatr Gastroenterol Nutr. 2010 ; 50: 212-218
59. Strijbosch RA, Lee S, Arsenault DA, et al. Fish oil prevents essential fatty acid deficiency and enhances growth: clinical and biochemical implications. Metabolism. 2008 ; 57: 698-707
60. Mallah HS, Brown MR, Rossi TM, Block RC. Parenteral fish oil-associated burr cell anemia. J Pediatr. 2010 ; 156: 324 e321-326
61. Germany: Fresenius Kabi AG ; 2001 :
62. Bays HE. Safety considerations with omega-3 fatty acid therapy. Am J Cardiol. 2007 ; 99: 35C - 43C
63. Harris WS. Expert opinion: omega-3 fatty acids and bleeding-cause for concern?. Am J Cardiol. 2007 ; 99: 44C - 46C
64. Bays HE. Safety considerations with omega-3 fatty acid therapy. Am J Cardiol. 2007 ; 99 (6A). 35C - 43C
65. El-Badry AM, Graf R, Clavien PA. Omega 3-omega 6: what is right for the liver?. J Hepatol. 2007 ; 47 (5). 718-725
66. De Vizia B, Raia V, Spano C, Pavlidis C, Coruzzo A, Alessio M. Effect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis. JPEN J Parenter Enteral Nutr. 2003 ; 27 (1). 52-57
67. Thienprasert A, Samuhaseneetoo S, Popplestone K, West AL, Miles EA, Calder PC. Fish oil n-3 polyunsaturated fatty acids selectively affect plasma cytokines and decrease illness in Thai schoolchildren: a randomized, double-blind, placebo-controlled intervention trial. J Pediatr. 2009 ; 154 (3). 391-395
68. Vaisman N, Kaysar N, Zaruk-Adasha Y, et al. Correlation between changes in blood fatty acid composition and visual sustained attention performance in children with inattention: effect of dietary n-3 fatty acids containing phospholipids. Am J Clin Nutr. 2008 ; 87 (5). 1170-1180
69. Smithers LG, Gibson RA, McPhee A, Makrides M. Effect of long-chain polyunsaturated fatty acid supplementation of preterm infants on disease risk and neurodevelopment: a systematic review of randomized controlled trials. Am J Clin Nutr. 2008 ; 87 (4). 912-920
70. Schmocker C, Weylandt KH, Kahlke L, et al. Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines. Hepatology. 2007 ; 45 (4). 864-869
71. Novak TE, Babcock TA, Jho DH, Helton WS, Espat NJ. NF-kappa B inhibition by omega-3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription. Am J Physiol Lung Cell Mol Physiol. 2003 ; 284 (1). L84 - L89
72. Malhi H, Gores GJ. Cellular and molecular mechanisms of liver injury. Gastroenterology. 2008 ; 134 (6). 1641-1654
73. Li J, Gong YM, Wu J, Wu WJ, Cai W. Anti-tumor necrosis factor-alpha monoclonal antibody alleviates parenteral nutrition-associated liver disease in mice. JPEN J Parenter Enteral Nutr. 2012 ; 36 (2). 219-225
74. Carter BA, Taylor OA, Prendergast DR, et al. Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR. Pediatr Res. 2007 ; 62 (3). 301-306
75. Kurvinen A, Nissinen MJ, Andersson S, et al. Parenteral plant sterols and intestinal failure-associated liver disease in neonates. J Pediatr Gastroenterol Nutr. 2012 ; 54 (6). 803-811
76. Sigalet D, Boctor D, Robertson M, et al. Improved outcomes in paediatric intestinal failure with aggressive prevention of liver disease. Eur J Pediatr Surg. 2009 ; 19 (6). 348-353
77. de Meijer VE, Gura KM, Le HD, Meisel JA, Puder M. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience. JPEN J Parenter Enteral Nutr. 2009 ; 33 (5). 541-547
78. Goulet O, Antebi H, Wolf C, et al. A new intravenous fat emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil: a single-center, double-blind randomized study on efficacy and safety in pediatric patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr. 2010 ; 34 (5). 485-495
79. Angsten G, Finkel Y, Lucas S, Kassa AM, Paulsson M, Lilja HE. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with omega-6/9 lipid emulsions. JPEN J Parenter Enteral Nutr. 2012 ; 36 (5). 587-595